Risks of medication-related osteonecrosis of the jaw in cancer patients (RDH Magazine) by Jill Meyer-Lippert April 01, 2021 Antiangiogenisis Avastin Bisphosphonates Cancer denonsumab dental Dental Oncology Dry Mouth infection medication-related osteonecrosis of the jaw MRONJ oncology oral care Oral Health Oral Hygiene Osteonecrosis prevention Side Effect Support Side Effects survivorship targeted therapies tooth decay Click the image below to read, "Risks of medication-related osteonecrosis of the jaw in cancer patients" in the April 2021 edition of RDH Magazine (pages 38 & 39). Share Share on Facebook Tweet Tweet on Twitter Pin it Pin on Pinterest Offers From Our Partners: